Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer reported by I. Gioulbasanis et al
January 8th, 2009
In this recently published article, scientists in Greece conducted a study "To determine the tolerability and efficacy of the combination of gefitinib with gemcitabine plus vinorelbine in metastatic breast cancer (MBC) patients, pre-treated with anthracyclines and taxanes. Women with measurable MBC pretreated with anthracycline- and taxane-based chemotherapy received oral gefitinib (250 mg/day) continuously combined with intravenous gemcitabine 1000 mg/m(2) and vinorelbine 25 mg/m(2) on day 1, every 2 weeks." "The first 10 enrolled patients were evaluated for the safety and tolerability of the proposed fixed-dose regimen. The study was discontinued prematurely due to...
Source: Women's Health Weekly (2009-01-08)
|
